Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 43: 1657-1659, 1997;
This Article
Right arrow Full Text
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (50)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zivelin, A.
Right arrow Articles by Seligsohn, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zivelin, A.
Right arrow Articles by Seligsohn, U.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 1997;43:1657-1659.)
© 1997 American Association for Clinical Chemistry, Inc.

Technical Briefs

Improved Method for Genotyping Apolipoprotein E Polymorphisms by a PCR-Based Assay Simultaneously Utilizing Two Distinct Restriction Enzymes

Ariella Zivelin, Nurit Rosenberg, Hava Peretz, Yonit Amit, Nurit Kornbrot and Uri Seligsohna

Inst. of Thrombosis and Hemostasis, Sheba Med. Center, Tel Hashomer, Israel
a author for correspondence: fax 972-3-5351568,

Apolipoprotein E (apo E) is a protein that plays an essential role in lipid metabolism and distribution (1). The apo E gene is polymorphic, and its three alleles code for isoforms E2, E3, and E4, which differ by single-amino-acid substitutions (2). The apo E3 allele is the predominant isoform in all populations studied. The apo E4 allele is associated with increased total serum cholesterol and greater odds for coronary heart disease (3); it also constitutes a major risk factor for Alzheimer disease (4). The apo E2 allele seems to have a protective effect against Alzheimer disease and is associated with longevity (5). Consequently, interest in examining individual patients and study groups for the apo E isoforms is growing. In this communication we describe a simple procedure that facilitates the genotyping of the apo E polymorphisms.

In the common apo E3 polymorphism, TGC encodes for Cys112, and CGC encodes for Arg158. In the apo E2 another TGC codon results in Cys158, whereas in the apo E4 a different CGC codon gives rise to Arg112. . . [Full Text of this Article]


References




The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. PsychiatryHome page
S. M. Laws, R. Perneczky, A. Drzezga, J. Diehl-Schmid, B. Ibach, J. Bauml, T. Eisele, H. Forstl, A. Kurz, and M. Riemenschneider
Association of the Tau Haplotype H2 With Age at Onset and Functional Alterations of Glucose Utilization in Frontotemporal Dementia
Am J Psychiatry, October 1, 2007; 164(10): 1577 - 1584.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Riemenschneider, L. Konta, P. Friedrich, S. Schwarz, K. Taddei, F. Neff, A. Padovani, H. Kolsch, S. M. Laws, N. Klopp, et al.
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease
Hum. Mol. Genet., August 15, 2006; 15(16): 2446 - 2456.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
N. Ghebranious, L. Ivacic, J. Mallum, and C. Dokken
Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology
Nucleic Acids Res., October 4, 2005; 33(17): e149 - e149.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M Pinholt, J L Frederiksen, P S Andersen, and M Christiansen
Apo E in multiple sclerosis and optic neuritis: the Apo E-o4 allele is associated with progression of multiple sclerosis
Multiple Sclerosis, October 1, 2005; 11(5): 511 - 515.
[Abstract] [PDF]

Home page
 JNMHome page
A. Drzezga, T. Grimmer, M. Riemenschneider, N. Lautenschlager, H. Siebner, P. Alexopoulus, S. Minoshima, M. Schwaiger, and A. Kurz
Prediction of Individual Clinical Outcome in MCI by Means of Genetic Assessment and 18F-FDG PET
J. Nucl. Med., October 1, 2005; 46(10): 1625 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. L. Slattery, C. Sweeney, M. Murtaugh, K. N. Ma, J. D. Potter, T. R. Levin, W. Samowitz, and R. Wolff
Associations between apoE genotype and colon and rectal cancer
Carcinogenesis, August 1, 2005; 26(8): 1422 - 1429.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Drzezga, M. Riemenschneider, B. Strassner, T. Grimmer, M. Peller, A. Knoll, S. Wagenpfeil, S. Minoshima, M. Schwaiger, and A. Kurz
Cerebral glucose metabolism in patients with AD and different APOE genotypes
Neurology, January 11, 2005; 64(1): 102 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
W. Marz, H. Scharnagl, M. M. Hoffmann, B. O. Boehm, and B. R. Winkelmann
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)
Eur. Heart J., December 1, 2004; 25(23): 2109 - 2119.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
H. Wang, J. Li, H. Liu, Q. Liu, Q. Mei, Y. Wang, J. Zhu, N. He, and Z. Lu
Label-free hybridization detection of a single nucleotide mismatch by immobilization of molecular beacons on an agarose film
Nucleic Acids Res., June 15, 2002; 30(12): e61 - e61.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Riemenschneider, S. Wagenpfeil, J. Diehl, N. Lautenschlager, T. Theml, B. Heldmann, A. Drzezga, T. Jahn, H. Forstl, and A. Kurz
Tau and A{beta}42 protein in CSF of patients with frontotemporal degeneration
Neurology, June 11, 2002; 58(11): 1622 - 1628.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M Riemenschneider, J Diehl, U Muller, H Forstl, and A Kurz
Apolipoprotein E polymorphism in German patients with frontotemporal degeneration
J. Neurol. Neurosurg. Psychiatry, May 1, 2002; 72(5): 639 - 641.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Inbal, D. Freimark, B. Modan, A. Chetrit, S. Matetzky, N. Rosenberg, R. Dardik, Z. Baron, and U. Seligsohn
Synergistic Effects of Prothrombotic Polymorphisms and Atherogenic Factors on the Risk of Myocardial Infarction in Young Males
Blood, April 1, 1999; 93(7): 2186 - 2190.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. G. Donohoe, A. Salomaki, T. Lehtimaki, K. Pulkki, and V. Kairisto
Rapid Identification of Apolipoprotein E Genotypes by Multiplex Amplification Refractory Mutation System PCR and Capillary Gel Electrophoresis
Clin. Chem., January 1, 1999; 45(1): 143 - 146.
[Full Text] [PDF]

Home page
 CirculationHome page
O. Shpilberg, I. Rabi, K. Schiller, R. Walden, D. Harats, K.S. Tyrrell, B. Coller, and U. Seligsohn
Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein {alpha}IIb{beta}3 (GPIIb/IIIa) and {alpha}v{beta}3 Receptors Are Not Protected From Atherosclerosis
Circulation, March 5, 2002; 105(9): 1044 - 1048.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.